Thermo Fisher Scientific, Inc. (TMO)
673.82
-2.72
(-0.40%)
USD |
NYSE |
Oct 23, 16:00
673.70
-0.12
(-0.02%)
After-Hours: 20:00
Thermo Fisher Scientific Enterprise Value : 284.58B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 284.58B |
| October 22, 2026 | 285.59B |
| October 21, 2026 | 292.05B |
| October 20, 2026 | 289.59B |
| October 19, 2026 | 286.64B |
| October 16, 2026 | 290.56B |
| October 15, 2026 | 292.96B |
| October 14, 2026 | 284.35B |
| October 13, 2026 | 280.59B |
| October 12, 2026 | 280.30B |
| October 09, 2026 | 278.74B |
| October 08, 2026 | 276.50B |
| October 07, 2026 | 280.23B |
| October 06, 2026 | 278.21B |
| October 05, 2026 | 285.67B |
| October 02, 2026 | 277.55B |
| October 01, 2026 | 276.70B |
| September 30, 2026 | 285.03B |
| September 29, 2026 | 289.89B |
| September 28, 2026 | 289.51B |
| September 25, 2026 | 288.18B |
| September 24, 2026 | 289.43B |
| September 23, 2026 | 284.59B |
| September 22, 2026 | 282.09B |
| September 21, 2026 | 282.18B |
| Date | Value |
|---|---|
| September 18, 2026 | 279.47B |
| September 17, 2026 | 282.01B |
| September 16, 2026 | 278.36B |
| September 15, 2026 | 275.75B |
| September 14, 2026 | 265.49B |
| September 11, 2026 | 264.08B |
| September 10, 2026 | 261.63B |
| September 09, 2026 | 262.55B |
| September 08, 2026 | 261.57B |
| September 04, 2026 | 265.55B |
| September 03, 2026 | 267.26B |
| September 02, 2026 | 263.61B |
| September 01, 2026 | 260.64B |
| August 31, 2026 | 266.77B |
| August 28, 2026 | 268.65B |
| August 27, 2026 | 271.80B |
| August 26, 2026 | 272.91B |
| August 25, 2026 | 270.86B |
| August 24, 2026 | 271.08B |
| August 21, 2026 | 271.27B |
| August 20, 2026 | 270.64B |
| August 19, 2026 | 265.46B |
| August 18, 2026 | 256.40B |
| August 17, 2026 | 255.09B |
| August 14, 2026 | 256.12B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 50.99B |
| Danaher Corp. | 184.25B |
| Illumina, Inc. | 42.04B |
| Bio-Rad Laboratories, Inc. | 9.642B |
| Revvity, Inc. | 20.03B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.739B |
| Revenue (Quarterly) | 12.14B |
| Total Expenses (Quarterly) | 10.40B |
| EPS Diluted (Quarterly) | 4.64 |
| Gross Profit Margin (Quarterly) | 38.50% |
| Profit Margin (Quarterly) | 14.33% |
| Earnings Yield | 2.81% |
| Operating Earnings Yield | 3.64% |